5172 studies found for:    "Kidney Diseases"
Show Display Options
Rank Status Study
21 Completed Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Interventions: Drug: Sirolimus;   Other: Standard
22 Terminated Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Interventions: Drug: Sirolimus;   Drug: conventional therapy
23 Active, not recruiting Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency
Condition: Autosomal Dominant Polycystic Kidney Disease.
Interventions: Drug: Octreotide-LAR;   Other: Saline solution.
24 Recruiting The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Everolimus;   Drug: Calcineurin inhibitors maintenance
25 Enrolling by invitation Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Drug: Tolvaptan (OPC-41061)
26 Unknown  Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients
Conditions: Chronic Kidney Disease Stage 4;   Chronic Kidney Disease Stage 3
Intervention: Drug: Aspirin
27 Completed
Has Results
Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Placebo;   Drug: Everolimus
28 Completed Chronic Kidney Disease Prevention of An-Lo District, Keelung
Conditions: Chronic Kidney Disease;   End Stage Renal Disease;   Death
Intervention: Behavioral: multidisciplinary predialysis education
29 Enrolling by invitation Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney Disease
Conditions: Cardiovascular Disease;   Chronic Kidney Disease;   Chronic Renal Disease;   Hypertension
Intervention: Behavioral: exercise aerobic
30 Completed Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
Conditions: Radiocontrast-Induced Nephropathy;   Chronic Kidney Disease;   Diabetes Mellitus
Interventions: Drug: N-acetylcysteine;   Drug: Placebo
31 Recruiting Improving Evidence-Based Primary Care for Chronic Kidney Disease
Conditions: Chronic Kidney Disease;   Chronic Kidney Insufficiency;   Chronic Renal Diseases;   Chronic Renal Insufficiency;   Kidney Insufficiency, Chronic
Interventions: Other: Facilitated Clinical Decision Support;   Other: Clinical Decision Support Only
32 Recruiting Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
Conditions: End-Stage Renal Disease;   Stage 5 Chronic Kidney Disease
Interventions: Drug: Telavancin;   Procedure: Pharmacokinetic Blood Sampling
33 Recruiting Polycystic Kidney Disease Data Repository
Condition: Polycystic Kidney Disease
Intervention:
34 Completed Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia
Conditions: End Stage Renal Disease;   Chronic Kidney Disease;   Hyperphosphatemic;   Kidney Disease
Interventions: Drug: AMG 223;   Drug: Placebo
35 Recruiting Pyridorin in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Diabetic Kidney Disease
Interventions: Drug: Pyridorin;   Drug: Placebo
36 Terminated
Has Results
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
Conditions: Proteinuric Kidney Disease;   Diabetic Nephropathy;   Hypertensive Nephrosclerosis;   IgA Nephropathy;   Focal Segmental Glomerulosclerosis;   Glomerulopathy (Obesity-associated);   Glomerulonephritis, Membranous
Interventions: Drug: Aliskiren;   Drug: Valsartan
37 Completed Kidney Disease Biomarkers
Conditions: Kidney Disease;   Glomerular Disease;   Idiopathic Nephrotic Syndrome;   Focal Segmental Glomerulosclerosis;   Collapsing Glomerulopathy
Intervention:
38 Completed Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting.
Conditions: Chronic Kidney Disease;   Diabetic Nephropathy
Intervention: Behavioral: Community-based Integrated CKD Care
39 Completed
Has Results
Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Polycystic Kidney Diseases
Intervention: Drug: Rapamune
40 Active, not recruiting Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
Condition: Polycystic Kidney Disease
Intervention: Dietary Supplement: Niacinamide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years